Secondly, our findings were derived from in vitro experiments, hence the effect of ARA and 5-LOX inhibitor on CD8+ T cells and their capability in promoting repigmentation in vitiligo treatment still need further validation in vivo. This evidence concerns the gene CD8A and vitiligo.